All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Did You Take Any Medication Except the Study Drug for Vomiting During This Period | NCIT_C107628 | [A question about whether an individual took any medication, except the study drug, for vomiting during the specified time period.] |
| Ann Arbor Stage I Marginal Zone Lymphoma | NCIT_C68678 | [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).] |
| Marginal Zone Lymphoma by Ann Arbor Stage | NCIT_C141258 | [An anatomic stage for marginal zone lymphoma based on the Ann Arbor classification criteria.] |
| Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma | NCIT_C27308 | [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).] |
| Did You Take Any Medication Except the Study Drug for Nausea During This Period | NCIT_C107629 | [A question about whether an individual took any medication, except the study drug, for nausea during the specified time period.] |
| Ann Arbor Stage II Marginal Zone Lymphoma | NCIT_C68679 | [Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (PDQ)] |
| Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma | NCIT_C8843 | [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3).] |
| Laser Interstitial Thermal Therapy | NCIT_C68680 | [A thermal ablation therapy in which neoplasms are heated with prolonged and moderate temperature elevations. It results in coagulative necrosis in the heated tissue.] |
| High-Intensity Focused Ultrasound Ablation | NCIT_C68681 | |
| Ann Arbor Stage III Marginal Zone Lymphoma | NCIT_C68682 | [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S).] |
| Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma | NCIT_C8844 | [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S).] |
| Ann Arbor Stage IV Marginal Zone Lymphoma | NCIT_C68683 | [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid.] |
| Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | NCIT_C8845 | [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid.] |
| Recurrent Marginal Zone Lymphoma | NCIT_C68684 | [The reemergence of marginal zone lymphoma after a period of remission.] |
| Marginal Zone Lymphoma | NCIT_C4341 | [A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues. It is characterized by the presence of small to medium sized atypical lymphocytes. It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of extranodal disease; and splenic marginal zone B-cell lymphoma, which affects the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.] |
| Recurrent B-Cell Non-Hodgkin Lymphoma | NCIT_C8841 | [The reemergence of B-cell non-Hodgkin lymphoma after a period of remission.] |
| Decimole | NCIT_C68685 | [A unit of amount of substance equal to one tenth of a mole (10E-1 mole).] |
| Unit of Amount of Substance | NCIT_C48453 | [Physical quantity that measures the number of elementary entities in the object compared with the number of elementary entities (atoms, molecules, ions, electrons, or particles) in 0.012 kilogram of pure carbon-12.] |
| Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma | NCIT_C68686 | [Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ)] |
| Aggressive Adult Non-Hodgkin Lymphoma | NCIT_C8492 | [An aggressive non-Hodgkin lymphoma occurring in adults. Representative examples include Burkitt lymphoma, precursor B-lymphoblastic lymphoma, precursor T-lymphoblastic lymphoma, and adult T-cell lymphoma/leukemia.] |